FDA Approves Sofdra (sofpironium) Topical Gel for the Treatment of Primary Axillary Hyperhidrosis

Philadelphia and Phoenix US, 20 June 2024 -- Clinical dermatology company, Botanix Pharmaceuticals Ltd. (ASX:BOT, Botanix or the Company), is pleased to announce the US Food and Drug Administration (FDA) approval of Sofdra™ (sofpironium) gel...

Articles similaires

‘Transformative event’: Clinical dermatology firm Botanix gets US FDA nod for sweat-stopper gel

thewest.com.au - 20/Jun 02:30

Clinical dermatology company Botanix has secured US Food and Drug Administration approval for its gel aimed at treating excessive sweating.

ASX Health Stocks: Control Bionics surges over 50pc after TGA approval of DROVE wheelchair

stockhead.com.au - 20/Jun 00:53

Control Bionics' shares surge after TGA approval, and Botanix Pharma granted US FDA approval for Sofdra (sofpironium) gel. ...

Perth biotech Botanix to raise $70m following FDA nod for sweat-stopper gel

thewest.com.au - 21/Jun 03:24

Biotech Botanix says it has received firm commitments to raise $70 million from institutional investors just a day after it received US Food and Drug...

Genting and TauRx applying for UK, US regulators' approval for Alzheimer's drug

nst.com.my - 20/Jun 21:55

KUALA LUMPUR: Genting Bhd, along with its partner TauRx Pharmaceuticals Ltd., is currently seeking approval from both the United Kingdom's Medicines...

FDA Approves Ohtuvayre (ensifentrine) for the Maintenance Treatment of Chronic Obstructive Pulmonary Disease (COPD)

drugs.com - 26/Jun 21:06

LONDON and RALEIGH, N.C., June 26, 2024 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the...

Imricor starts global trial for US FDA approval

stockhead.com.au - 21/Jun 04:48

Imricor’s VISABL-AFL global clinical trial supporting US Food and Drug Administration (FDA) approval has kicked off. ...

FDA Approves KEYTRUDA + Chemo for Primary Advanced, Recurrent Endometrial Carcinoma

drugs.com - 21/Jun 22:55

FRIDAY, June 21, 2024 -- The U.S. Food and Drug Administration has approved Keytruda (pembrolizumab) plus chemotherapy as treatment for adult...

Recce Pharmaceuticals Receives Ethics Approval to Broaden RECCE® 327 Gel Trials Across all Topical Bacterial Skin Infections

healthtechzone.com - 25/Jun 12:00

Synaptogenix gets US FDA authorization of IND application for clinical trial for Bryostatin─1 to treat multiple sclerosis

pharmabiz.com - 01/Jul 00:00

Synaptogenix, Inc., an emerging biopharmaceutical company developing therapeutics for neurodegenerative disorders, announced that the Food & Drug...

Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year

asianewsday.com - 21/Jun 20:29

Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of the most common sleep-related breathing...

Les derniers communiqués

Adobe Brings Conversational AI to Trillions of PDFs with the New AI Assistant in Reader and Acrobat
Adobe - 21/02/2024
Laura Frigenti takes the Helm as Chief Executive Officer of the Global Partnership for Education
Global Partnership for Education - 05/12/2022

Rubriques :

Articles similaires

Les derniers communiqués